Revolution Medicines, Inc 10-Q for FY2023 Q3
Revolution Medicines, Inc. (RVMD)
10-Q
2023-11-06
For: 2023-09-30
View Original
Added on
April 10, 2026
About this 10-Q
Revolution Medicines, Inc filed this 10-Q on November 6, 2023, covering the quarter ended September 30, 2023 (FY2023 Q3).
Headline figures
Quarter ended September 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $3.36M a year earlier
- Net loss
- $108.43M
- compared with a net loss of $73.33M a year earlier
- Diluted EPS
- -$0.99
- compared with -$0.87 a year earlier